BetterLife Pharma Inc (BETRF) Stock Price, Trades & News

BetterLife Pharma Inc is a biopharmaceutical company engaged in the development of patented pharmaceuticals. It is an emerging biotechnology company mainly focused on developing compounds for the treatment of mental disorders. It is also refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight viral infections. The Company operates in one industry segment, development and commercialization of patented pharmaceuticals within one geographical area.

Financial Strength

3/10

Name	Current	Vs Industry
Cash-To-Debt	0.01
Equity-to-Asset	-44.47
Debt-to-Equity	-0.13
Debt-to-EBITDA	-1.84
Piotroski F-Score	4/9	0 1 2 3 4 5 6 7 8 9
WACC vs ROIC		WACC ROIC

Growth Rank

	Name	Current	Vs Industry		Vs History
	3-Year EBITDA Growth Rate	56.2
	3-Year EPS without NRI Growth Rate	47.7
	3-Year FCF Growth Rate	38.3
	3-Year Book Growth Rate	18.7

Momentum Rank

8/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	98.64
	9-Day RSI	95.23
	14-Day RSI	90.54
	3-1 Month Momentum %	0.62
	6-1 Month Momentum %	47.68
	12-1 Month Momentum %	-24.58

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	0.03
	Quick Ratio	0.03

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	3-Year Average Share Buyback Ratio	-19
	Shareholder Yield %	2.21

Profitability Rank

1/10

	Name	Current	Vs Industry		Vs History
	ROA %	-370.42
	ROIC %	-166.3
	3-Year ROIIC %	1315.9
	Moat Score	2
	Tariff Resilience Score	4

GF Value Rank

	Name	Current	Vs Industry		Vs History
	Price-to-Owner-Earnings	149.73
	EV-to-EBIT	-44.38
	EV-to-EBITDA	-44.38
	EV-to-FCF	-80.48
	Earnings Yield (Greenblatt) %	-2.25
	FCF Yield %	-1.48

GF Value™

BETRF

Warning Signs

Warning! GuruFocus detected 1 Severe warning sign with BETRF. Try a 7-Day Free Trial to check it out.

BetterLife Pharma Inc Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

BetterLife Pharma Inc Stock Events

Financials Calendars

	Event	Date	Price ($)
	0.1:1 Stock Split	2020-06-26	1.14 (+0.14%)
	0.1:1 Stock Split	2015-04-20	0.01 (-98.00%)

Show

Entries

Guru Commentaries on OTCPK:BETRF

No articles.

Press Release

	Subject	Date
	Thinking about buying stock in Allarity Therapeutics, Better Home & Finance Holding, Top KingWin, Axcella Health, or Metatron Apps?	2023-08-31
	BetterLife Pharma Provides Update on Proposed Acquisition of Altum and its Regulatory Guidance and Updated Clinical Development Plan	2020-07-27
	BetterLife Pharma Announces Consolidation of its Common Shares	2020-06-25
	BetterLife Pharma Updates Shareholders on its Proposed Acquisition of Altum	2020-06-11
	BetterLife Pharma Announces OTC Trading Symbol Change to "BETRF" Effective June 9, 2020	2020-06-09
	BetterLife Pharma Updates Shareholders on its Proposed Acquisition of Altum	2020-06-04
	BetterLife Pharma Secures Lock-Up Agreements From Shareholders of Altum	2020-05-25
	BetterLife Pharma Announces Appointment of Dr. Eleanor Fish, a leading expert on interferon activity against Covid-19, to its Advisory Board	2020-05-19
	BetterLife Pharma announces release of exploratory study on treatment of Covid-19 patients in Wuhan with Interferon	2020-05-15
	BetterLife Pharma announces Interferon Alpha-2b Covid-19 news regarding its emergence as a potential treatment for COVID-19	2020-05-13

10/Page

Articles on BetterLife Pharma Inc

No articles.

Headlines

No news.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.